В. А. Алиев
Moscow Clinical Scientific Center · 68 works · 112 citations · h-index 4
Top works
- Downregulation of AKR1B10 expression in colorectal cancer
- [Downregulation of AKR1B10 gene expression in colorectal cancer].
- “Watch and wait” strategy (active dynamic follow-up) in the management of rectal cancer patients with a complete clinical response
- [Combined treatment for rectal cancer using different radiomodification means].
- [Neoadjuvant chemotherapy for colorectal cancer--time to learn a new treatment strategy?].
- Maintenance therapy following first-line chemotherapy in metastatic colorectal cancer: toxicity and efficacy—single-institution experience
- Surgical strategy for locally-advanced right-sided colonic cancer
- Role of adjuvant chemotherapy in patients with rectal cancer after preoperative chemoradiotherapy: results of a retrospective study
- Short-term and long-term treatment outcomes in patients with lower and middle rectal cancer with complete clinical and pathomorphological response after comprehensive treatment
- COMBINATION NEOADJUVANT THERMOCHEMICAL THERAPY IN PATIENTS WITH RECTAL CANCER
- Methodological aspects of complex therapy of locally advanced rectal cancer
- Выявление соматических мутаций в генахKRAS,BRAF,PIK3CAу больных колоректальным раком с помощью биологических микрочипов
- A prospective study of prognostic role of plasma circulating tumor DNA (ctDNA) in patients (pts) with early-stage malignancies.
- Comprehensive treatment of rectal cancer patients with synchronous distant metastases
- The Role of the Intestinal Microbiome in the Immunotherapy of Colon Cancer
- Metastatic colorectal cancer. Evolution of treatment strategies: surgeons’ point of view
- Colorectal cancer with synchronous lung metastases: clinical characteristics, treatment, prognosis
- Short-term and long-term outcomes of laparoscopic right hemicolectomy with d3 lymph node dissection: experience of one clinic
- Biochip detection of KRAS, BRAF, and PIK3CA somatic mutations in colorectal cancer patients
- FOLFOXIRI in patients with colon cancer and isolated non-resectable liver metastases: phase II prospective non-randomized single-center study